Tectonic Therapeutic, Inc.
TECX
NASDAQ·Healthcare·Biotechnology·Mkt cap $580.2M
$30.75
▲ +2.77%
P/E
-6.73
Mkt Cap
$580.2M
52-Wk Range
$14.39–$39.53
52-Week Range
$14.39 - $39.53
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 88.5% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary GEODe platform enabling efficient GPCR drug discovery and development
- Focused pipeline targeting high-value indications with significant unmet medical needs
- Expertise in biologic modulation of GPCRs, a large but underexploited drug target class
- Clinical validation through ongoing Phase 1 trials demonstrating platform viability
Bear Case
1 risk
- Low volatility (beta 0.2).
Growth
Stable outlook
Advancement of RXFP1 agonist through Phase 1b and into Phase 2 trials for HFpEF
Value
Deep value opportunity - significant discount to Biotech & Therapeutics peers
Momentum
Strong
+5.7% over 3m
Quality
Loss-making
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying TECX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 6, 2026
Reported EPS of -$1.18 vs -$1.35 consensus (+12.6% surprise).
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+12.6%
Revenue trend · last 8Q
—
—
—
—
—
—
—
—
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$0
$0
$0
$0
$0
$0
$0
$0
Margins · last 8Q
No margin history available.
Wall Street consensus
2 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Oppenheimer · Sep 1, 2026
vs Industry
How TECX stacks vs Biotechnology
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related